GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » Cash Conversion Cycle

GE HealthCare Technologies (GE HealthCare Technologies) Cash Conversion Cycle : 32.78 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

GE HealthCare Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 57.21.
GE HealthCare Technologies's Days Inventory for the three months ended in Dec. 2023 was 61.15.
GE HealthCare Technologies's Days Payable for the three months ended in Dec. 2023 was 85.58.
Therefore, GE HealthCare Technologies's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 32.78.


GE HealthCare Technologies Cash Conversion Cycle Historical Data

The historical data trend for GE HealthCare Technologies's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Cash Conversion Cycle Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
- 14.28 27.75 38.49 32.34

GE HealthCare Technologies Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.03 36.24 39.22 40.79 32.78

Competitive Comparison of GE HealthCare Technologies's Cash Conversion Cycle

For the Health Information Services subindustry, GE HealthCare Technologies's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Cash Conversion Cycle falls into.



GE HealthCare Technologies Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

GE HealthCare Technologies's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=60.21+64.57-92.44
=32.34

GE HealthCare Technologies's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=57.21+61.15-85.58
=32.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GE HealthCare Technologies  (NAS:GEHC) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


GE HealthCare Technologies Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
Executives
Kevin Michael O'neill officer: CEO, PDx 500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott officer: CEO, Ultrasound 500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro officer: Chief Financial Officer ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela officer: CEO, Imaging 500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout officer: Chief Technology Officer 500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski officer: Ch. Supply Chain & Serv. Ofc. 500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr director GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg director 100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick officer: CEO, Patient Care Solutions 500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman director 21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic director ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell director 8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden director C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez officer: GC & Corporate Secretary GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061